AICUBE signs an agreement with Bartels Mikrotechnik for the development of the microfluidic system.

AICUBE and Bartels Mikrotechnik strategic partners for the development of DOC.D©, an innovative non-invasive device for measuring salivary glucose in type II diabetic patients.

Milan 31 March 2021 - AICUBE innovative startup, based in Milan, strongly oriented to proactive prevention and predictive medicine through Machine Learning algorithms, has signed a contract with Bartels Mikrotechnik medical engineering company in the development of a microfluidics solution of the AICUBE project.

In 2020, AICUBE achieved important goals in research, device development and capital raising. It has therefore begun the industrialization process that will take it to the next stage of industrial prototyping. The relationship with Bartels Mikrotechnik rises from an intense period of evaluation of various companies, universities and research centers in the field of microfluidics with the aim of finding the best partner for this important phase of the company. Bartels Mikrotechnik is the third company, after PQ Design Group and ATLAS Advanced Technologies, with which AICUBE decides to collaborate on the DOC.D© project.

Bartels Mikrotechnik is a globally active manufacturer and development service provider in the field of microfluidics. In the microEngineering division, the company supports industrial customers in the modification, adaptation and new development of high-performance and market-oriented product solutions through the innovative means of microsystems technology. The second division, microComponents, produces and distributes microfluidic products and systems, especially for miniaturized and portable applications. Our key products are micropumps that convey smallest quantities of gases or liquids and are used in a variety of ways in biotechnology, pharmaceuticals, medical technology and numerous other applications.

The development project of the DOC.D© device foresees different phases and the joining of new industrial partners in order to achieve our goal, that of increasing the level of secondary prevention. There is in fact the possibility to make early diagnosis of diseases that if diagnosed in time can be cured or at least reduce the associated complications.

Secondary prevention can be implemented by collecting the values of specific biomarkers on a daily or weekly basis in order to have statistically significant data.

Therefore, we have patented a device that non-invasively collects a saliva sample using an "augmented" electric toothbrush. The saliva sample is then moved to a unit (base) that measures the value of the reference biomarker such as glucose for diabetes or covid- like tests in the future (once clinically tested).

AICUBE signs an agreement with ATLAS - Advanced Technologies for industrial engineering.

AICUBE and ATLAS Advanced Technologies are strategic partners in the development of DOC.D©, an innovative non-invasive device for the measurement of salivary glucose in type II diabetic patients.

Milan February 16, 2021 - AICUBE innovative startup, based in Milan, strongly oriented to proactive prevention and predictive medicine through Machine Learning algorithms, has signed a contract with ATLAS Advanced Technologies consulting company in the development of an IoT solution for the HW-FW-SW architecture of the AICUBE project.

In 2020, AICUBE achieved important goals in research, device development and capital raising. It has therefore started the industrialization path that will lead it to the next phase of industrial prototyping. The relationship with ATLAS Advanced Technologies comes from an intense period of evaluation of different companies in the field of applied electronics, IOT and Cloud with the aim of finding the best partner for this important phase of the company. ATLAS Advanced Technologies is the second company, after PQ Design Group, with which AICUBE decides to collaborate on the DOC.D© project.

ATLAS Advanced Technologies is an Italian company specialized in the design and development of technological products. They provide solutions to create successful products. Strongly oriented to innovation and to the use of high reliability technologies for the IoT and Cloud world, for this project they field a team led by Valerio Grassi, physicist coming from the academic research world with international experience (CERN, Geneva). During his time at Unimi he has been Professor of Electronic Instrumentation for the School of Specialization in Health Physics.

The development project of the DOC.D© device foresees different phases and the joining of new industrial partners in order to achieve our goal, that of increasing the level of secondary prevention. There is in fact the possibility to make early diagnosis of diseases that if diagnosed in time can be cured or at least reduce the associated complications.

Secondary prevention can be implemented by collecting the values of specific biomarkers on a daily or weekly basis in order to have statistically significant data.

Therefore, we have patented a device that non-invasively collects a saliva sample using an "augmented" electric toothbrush. The saliva sample is then moved to a unit (base) that measures the value of the reference biomarker such as glucose for diabetes or covid-like tests in the future (once clinically tested).

AICUBE signs an agreement with Pq Design Group for industrial design.

AICUBE and Pq Design Group strategic partners for the development of DOC.D©, an innovative non-invasive device for the salivary glucose measurement in type II diabetic patients.

Milan January 22, 2021 - AICUBE innovative startup, based in Milan, strongly oriented to proactive prevention and predictive medicine through Machine Learning algorithms, has signed a contract with Pq Design Group consulting company in product design and development of innovative products.

In 2020 AICUBE reached important goals in research, device development and capital raising. It has therefore begun the path of industrialization that will lead it to the next stage of industrial prototyping. The relationship with Pq Design Group comes from an intense period of evaluation of different companies in the field of industrial design with the aim of finding the best partner for this important phase of the society.

Pq design Group is an Italian industrial design company specialized in product design and development of hi-tech products. They provide solutions to create successful products. Theirs is a consultancy that produces value, quality and innovation;

The development project of the DOC.D© device foresees different phases and the joining of new industrial partners in order to achieve our goal, that of increasing the level of secondary prevention. There is in fact the possibility to make early diagnosis of diseases that if diagnosed in time can be cured or at least reduce the associated complications.

Secondary prevention can be implemented by collecting the values of specific biomarkers on a daily or weekly basis in order to have statistically significant data.

Therefore, we have patented a device that non-invasively collects a saliva sample using an "augmented" electric toothbrush. The saliva sample is then moved to a unit (base) that measures the value of the reference biomarker such as glucose for diabetes or covid-like tests in the future (once clinically tested).